| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Charles River Laboratories International, Inc. (CRL) has 18 insiders with recent SEC Form 4 filings, including 0 buys and 44 sells. CRL is classified in the Life Sciences Tools & Services industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CEO | 210.7K | $33.82M | - | |
| COO | 65.9K | $10.59M | - | |
| VP | 29.2K | $4.68M | - | |
| VP | 27.4K | $4.39M | - | |
| CFO | 17.3K | $2.78M | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | 3M | 12M | SEC |
|---|---|---|---|---|---|---|---|---|---|---|
| Nov 15, 2022 | Parisotto Shannon M67 | Cevp, Disc &Safety Assessment | Sale+OE | 2,279 | $249.90 | $569,522.10 | -47.7% | +1.4% | -25.0% | |
| Nov 4, 2022 | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sell | 534 | $216.36 | $115,536.24 | -2.6% | +18.0% | -17.4% | |
| Aug 5, 2022 | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sell | 200 | $226.13 | $45,226.82 | -1.0% | -2.8% | -7.4% | |
| May 9, 2022 | Massaro George66 | Director | Sell | 178 | $230.96 | $41,110.18 | -0.5% | -3.6% | -18.1% | |
| Mar 3, 2022 | Smith David Ross63 | Corporate Executive VP &CFO | Sale+OE | 8,965 | $282.53 | $2,532,920.58 | -6.1% | -19.2% | -18.4% | |
| Feb 23, 2022 | Foster James C77 | Chairman, President And CEO | Sale+OE | 20,296 | $287.83 | $5,841,869.46 | -0.7% | -21.2% | -19.9% | |
| Feb 23, 2022 | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sell | 395 | $292.75 | $115,636.25 | -2.0% | -21.2% | -19.9% | |
| Feb 22, 2022 | Foster James C77 | Chairman, President And CEO | Sale+OE | 17,436 | $288.67 | $5,033,328.22 | -1.0% | -20.1% | -24.3% | |
| Feb 22, 2022 | Wallman Richard F81 | Director | Sell | 7,200 | $292.84 | $2,108,412.50 | -15.5% | -20.1% | -24.3% | |
| Feb 22, 2022 | Laplume Joseph W66 | EVP, Corp Strategy &Develop | Sale+OE | 1,539 | $291.55 | $448,697.57 | -2.4% | -20.1% | -24.3% |